NVS Novartis AG

Price (delayed)

$95.12

Market cap

$194.43B

P/E Ratio

13.3

Dividend/share

$3.78

EPS

$7.15

Enterprise value

$207.47B

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world ...

Highlights
The company's EPS has surged by 124% YoY and by 91% QoQ
The company's net income has surged by 114% YoY and by 90% QoQ
The quick ratio has soared by 105% since the previous quarter but it is down by 13% year-on-year
The company's equity rose by 22% QoQ but it fell by 21% YoY

Key stats

What are the main financial stats of NVS
Market
Shares outstanding
2.04B
Market cap
$194.43B
Enterprise value
$207.47B
Valuations
Price to book (P/B)
4.19
Price to sales (P/S)
4.18
EV/EBIT
12.76
EV/EBITDA
7.79
EV/Sales
4.45
Earnings
Revenue
$46.66B
EBIT
$16.26B
EBITDA
$26.63B
Free cash flow
$13.64B
Per share
EPS
$7.15
Free cash flow per share
$6.65
Book value per share
$22.7
Revenue per share
$22.76
TBVPS
$24.26
Balance sheet
Total assets
$99.95B
Total liabilities
$53.2B
Debt
$26.44B
Equity
$46.67B
Working capital
$4.09B
Liquidity
Debt to equity
0.57
Current ratio
1.16
Quick ratio
0.82
Net debt/EBITDA
0.49
Margins
EBITDA margin
57.1%
Gross margin
73.3%
Net margin
31.8%
Operating margin
20.9%
Efficiency
Return on assets
13.6%
Return on equity
31.5%
Return on invested capital
45.9%
Return on capital employed
22.1%
Return on sales
34.8%
Dividend
Dividend yield
3.97%
DPS
$3.78
Payout ratio
52.8%

NVS stock price

How has the Novartis AG stock price performed over time
Intraday
0.81%
1 week
0.75%
1 month
-1.15%
1 year
-5.16%
YTD
-5.79%
QTD
-1.66%

Financial performance

How have Novartis AG's revenue and profit performed over time
Revenue
$46.66B
Gross profit
$34.19B
Operating income
$9.77B
Net income
$14.85B
Gross margin
73.3%
Net margin
31.8%
The company's net income has surged by 114% YoY and by 90% QoQ
The company's net margin has surged by 104% QoQ and by 99% YoY
NVS's operating income is up by 23% year-on-year and by 5% since the previous quarter
NVS's operating margin is up by 14% year-on-year and by 13% since the previous quarter

Growth

What is Novartis AG's growth rate over time

Valuation

What is Novartis AG stock price valuation
P/E
13.3
P/B
4.19
P/S
4.18
EV/EBIT
12.76
EV/EBITDA
7.79
EV/Sales
4.45
The company's EPS has surged by 124% YoY and by 91% QoQ
The stock's P/E is 45% less than its last 4 quarters average of 24.3 and 32% less than its 5-year quarterly average of 19.7
The company's equity rose by 22% QoQ but it fell by 21% YoY
NVS's P/B is 13% above its 5-year quarterly average of 3.7 but 7% below its last 4 quarters average of 4.5
Novartis AG's revenue has increased by 7% YoY but it has decreased by 7% QoQ

Efficiency

How efficient is Novartis AG business performance
NVS's ROE has soared by 176% YoY and by 102% QoQ
The ROIC has soared by 167% year-on-year and by 78% since the previous quarter
Novartis AG's ROA has soared by 139% YoY and by 97% from the previous quarter
The company's return on sales has surged by 77% QoQ and by 71% YoY

Dividends

What is NVS's dividend history
DPS
$3.78
Dividend yield
3.97%
Payout ratio
52.8%
Recent dividends

Financial health

How did Novartis AG financials performed over time
NVS's total assets is 88% greater than its total liabilities
The quick ratio has soared by 105% since the previous quarter but it is down by 13% year-on-year
NVS's total liabilities is down by 29% since the previous quarter and by 8% year-on-year
The company's debt is 43% lower than its equity
The company's equity rose by 22% QoQ but it fell by 21% YoY
The debt to equity has grown by 21% YoY but it has contracted by 14% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.